Limaiem Faten, Azzabi Sonia, Sassi Asma, Mzabi Sabeh, Bouraoui Saadia
University of Tunis El Manar, Faculty of Medicine, Tunis, Tunisia.
Pan Afr Med J. 2018 Sep 27;31:62. doi: 10.11604/pamj.2018.31.62.11043. eCollection 2018.
Young people under the age of 40 with colorectal cancer represent a distinct subgroup with a more aggressive disease behaviour compared to older patients. This study aim to provide an updated overview on clinicopathological features, treatment and outcome of colorectal cancer in young adults under the age of 40. In our retrospective study, we reviewed 32 cases of colorectal cancer in young adults aged less than 40 years that were diagnosed at the pathology department of Mongi Slim hospital over a fifteen-year period (April 2000 - November 2014). Our study group included 13 male and 19 female patients (sex-ratio M/F = 0,68) between 17 and 39 years of age (mean = 31,25 years). The presenting clinical symptoms were dominated by altered bowel habits (n=17), followed by bleeding per rectum (n=16). Histopathological examination of the surgical and biopsy specimens established the diagnosis of mucinous adenocarcinoma in nine cases, well-differentiated adenocarcinoma in 11 cases, moderately differentiated adenocarcinoma in six cases, poorly differentiated adenocarcinoma in four cases and signet ring cell carcinoma in two cases. The tumours were classified after surgery as stage I (n = 2) (6%), stage IIA (n = 7) (22%), stage IIB (n=4) (13%), stage IIC (n=1) (3%), stage IIIB (n=8) (25%), stage IIIC (n= 4) (12%), stage IVA (n=4) (13%) and stage IVB (n=2) (6%). During the follow-up period which ranged between one month and 9 years, local recurrence of the tumour occurred in six cases, seven patients had hepatic metastases and seven patients died after a mean follow-up period of seven months. Molecular genetic studies are increasing the understanding of the pathobiology of colorectal cancer and may ultimately allow at-risk patients to be identified at an earlier stage.
40岁以下的结直肠癌青年患者是一个独特的亚组,与老年患者相比,其疾病行为更具侵袭性。本研究旨在提供40岁以下青年成人结直肠癌临床病理特征、治疗及预后的最新概述。在我们的回顾性研究中,我们回顾了15年期间(2000年4月至2014年11月)在蒙吉·斯利姆医院病理科诊断的32例年龄小于40岁的青年成人结直肠癌病例。我们的研究组包括13例男性和19例女性患者(性别比M/F = 0.68),年龄在17至39岁之间(平均 = 31.25岁)。主要临床症状以排便习惯改变为主(n = 17),其次是直肠出血(n = 16)。手术和活检标本的组织病理学检查确诊黏液腺癌9例、高分化腺癌11例、中分化腺癌6例、低分化腺癌4例和印戒细胞癌2例。术后肿瘤分期为Ⅰ期(n = 2)(6%)、ⅡA期(n = 7)(22%)、ⅡB期(n = 4)(13%)、ⅠIC期(n = 1)(3%)、ⅢB期(n = 8)(25%)、ⅡIC期(n = 4)(12%)、ⅣA期(n = 4)(13%)和ⅣB期(n = 2)(6%)。在为期1个月至9年的随访期内,6例出现肿瘤局部复发,7例发生肝转移,7例患者在平均随访7个月后死亡。分子遗传学研究正在加深对结直肠癌病理生物学的理解,并最终可能使高危患者在更早阶段被识别出来。